‘Fast Money’ traders Karen Finerman and Tim Seymour unveil their 2026 trader acronymsJanuary 13, 2026
Incyte CEO Bill Meury: Blood cancer therapy development is company’s central identityJanuary 13, 2026
Share Facebook Twitter LinkedIn Pinterest Email John Todaro, analyst at Needham, joins CNBC’s ‘Money Movers’ to discuss why his firm is upgrading Robinhood to a buy, what the incoming administration means for crypto and crypto trade, and more.